The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Characteristics and impact of Long Covid: Findings from an online survey
Open accessAbstract
Background: Long Covid is a public health concern that needs defining, quantifying, and describing. We aimed to explore the initial and ongoing symptoms of Long Covid following SARS-CoV-2 infection and describe its impact on daily life. Methods: We collected self-reported data through an online survey using convenience non-probability sampling. The survey enrolled adults who reported lab-confirmed (PCR or antibody) or suspected COVID-19 who were not hospitalised in the first two weeks of illness. This analysis was restricted to those with self-reported Long Covid. Univariate comparisons between those with and without confirmed COVID-19 infection were carried out and agglomerative hierarchical clustering was used to identify specific symptom clusters, and their demographic and functional correlates. Results: We analysed data from 2550 participants with a median duration of illness of 7.6 months (interquartile range (IQR) 7.1–7.9). 26.5% reported lab-confirmation of infection. The mean age was 46.5 years (standard deviation 11 years) with 82.8% females and 79.9% of participants based in the UK. 89.5% described their health as good, very good or excellent before COVID-19. The most common initial symptoms that persisted were exhaustion, chest pressure/tightness, shortness of breath and headache. Cognitive dysfunction and palpitations became more prevalent later in the illness. Most participants described fluctuating (57.7%) or relapsing symptoms (17.6%). Physical activity, stress, and sleep disturbance commonly triggered symptoms. A third (32%) reported they were unable to live alone without any assistance at six weeks from start of illness. 16.9% reported being unable to work solely due to COVID-19 illness. 37.0% reported loss of income due to illness, and 64.4% said they were unable to perform usual activities/duties. Acute systems clustered broadly into two groups: a majority cluster (n = 2235, 88%) with cardiopulmonary predominant symptoms, and a minority cluster (n = 305, 12%) with multisystem symptoms. Similarly, ongoing symptoms broadly clustered in two groups; a majority cluster (n = 2243, 88.8%) exhibiting mainly cardiopulmonary, cognitive symptoms and exhaustion, and a minority cluster (n = 283, 11.2%) exhibiting more multisystem symptoms. Belonging to the more severe multisystem cluster was associated with more severe functional impact, lower income, younger age, being female, worse baseline health, and inadequate rest in the first two weeks of the illness, with no major differences in the cluster patterns when restricting analysis to the lab-confirmed subgroup. Conclusion: This is an exploratory survey of Long Covid characteristics. Whilst this is a non-representative population sample, it highlights the heterogeneity of persistent symptoms, and the significant functional impact of prolonged illness following confirmed or suspected SARS-CoV-2 infection. To study prevalence, predictors and prognosis, research is needed in a representative population sample using standardised case definitions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
Puntmann, V. O., Carerj, M. L., Wieters, I., Fahim, M., Arendt, C., Hoffmann, J., Shchendrygina, A., Escher, F., Vasa-Nicotera, M., Zeiher, A. M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3557 · Cited by 2,208
Characterising long COVID: a living systematic review
Michelen, M., Manoharan, L., Elkheir, N., Cheng, V., Dagens, A., Hastie, C., O'Hara, M., Suett, J., Dahmash, D., Bugaeva, P., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005427 · Cited by 960
Self-citationHow and why patients made Long Covid
Callard, F., & Perego, E. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113426 · Cited by 924
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
Goërtz, Y. M. J., Van Herck, M., Delbressine, J. M., Vaes, A. W., Meys, R., Machado, F. V. C., Houben-Wilke, S., Burtin, C., Posthuma, R., Franssen, F. M. E., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00542-2020 · Cited by 847
Long-term Health Consequences of COVID-19
del Rio, C., Collins, L. F., & Malani, P. (2020) · JAMA · doi:10.1001/jama.2020.19719 · Cited by 711
Klok, F. A., Boon, G. J. A. M., Barco, S., Endres, M., Geelhoed, J. J. M., Knauss, S., Rezek, S. A., Spruit, M. A., Vehreschild, J., & Siegerink, B. (2020) · European Respiratory Journal · doi:10.1183/13993003.01494-2020 · Cited by 708
Validation of the Fatigue Severity Scale in a Swiss Cohort
Valko, P. O., Bassetti, C. L., Bloch, K. E., Held, U., & Baumann, C. R. (2008) · Sleep · doi:10.1093/sleep/31.11.1601 · Cited by 681
Ladds, E., Rushforth, A., Wieringa, S., Taylor, S., Rayner, C., Husain, L., & Greenhalgh, T. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-06001-y · Cited by 669
Cerebral Micro-Structural Changes in COVID-19 Patients – An MRI-based 3-month Follow-up Study
Lu, Y., Li, X., Geng, D., Mei, N., Wu, P.-Y., Huang, C.-C., Jia, T., Zhao, Y., Wang, D., Xiao, A., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100484 · Cited by 614
Dennis, A., Wamil, M., Alberts, J., Oben, J., Cuthbertson, D. J., Wootton, D., Crooks, M., Gabbay, M., Brady, M., Hishmeh, L., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048391 · Cited by 560
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re’em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2020) · medRxiv · doi:10.1101/2020.12.24.20248802 · Cited by 387
Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients
Petersen, M. S., Kristiansen, M. F., Hanusson, K. D., Danielsen, M. E., á Steig, B., Gaini, S., Strøm, M., & Weihe, P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1792 · Cited by 365
Long covid: How to define it and how to manage it
Nabavi, N. (2020) · BMJ · doi:10.1136/bmj.m3489 · Cited by 346
Bergamaschi, L., Mescia, F., Turner, L., Hanson, A. L., Kotagiri, P., Dunmore, B. J., Ruffieux, H., De Sa, A., Huhn, O., Morgan, M. D., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.010 · Cited by 338
Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID
Kingstone, T., Taylor, A. K., O'Donnell, C. A., Atherton, H., Blane, D. N., & Chew-Graham, C. A. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101143 · Cited by 319
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings
Nehme, M., Braillard, O., Alcoba, G., Aebischer Perone, S., Courvoisier, D., Chappuis, F., & Guessous, I. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5926 · Cited by 289
Patient-reported outcome measures after COVID-19: a prospective cohort study
Wong, A. W., Shah, A. S., Johnston, J. C., Carlsten, C., & Ryerson, C. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.03276-2020 · Cited by 207
Ward, H., Cooke, G. S., Atchison, C., Whitaker, M., Elliott, J., Moshe, M., Brown, J. C., Flower, B., Daunt, A., Ainslie, K., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100098 · Cited by 197
Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients
Bliddal, S., Banasik, K., Pedersen, O. B., Nissen, J., Cantwell, L., Schwinn, M., Tulstrup, M., Westergaard, D., Ullum, H., Brunak, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92045-x · Cited by 197
Huang, Y., Pinto, M. D., Borelli, J. L., Asgari Mehrabadi, M., Abrahim, H. L., Dutt, N., Lambert, N., Nurmi, E. L., Chakraborty, R., Rahmani, A. M., et al. (2022) · Clinical Nursing Research · doi:10.1177/10547738221125632 · Cited by 182
Long-term COVID-19 symptoms in a large unselected population
Cirulli, E. T., Schiabor Barrett, K. M., Riffle, S., Bolze, A., Neveux, I., Dabe, S., Grzymski, J. J., Lu, J. T., & Washington, N. L. (2020) · medRxiv · doi:10.1101/2020.10.07.20208702 · Cited by 172
Why the Patient-Made Term 'Long Covid' is needed
Perego, E., Callard, F. J., Stras, L., Melville-Jóhannesson, B., Pope, R., & Alwan, N. A. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16307.1 · Cited by 167
Self-citationGarcía-Abellán, J., Padilla, S., Fernández-González, M., García, J. A., Agulló, V., Andreo, M., Ruiz, S., Galiana, A., Gutiérrez, F., & Masiá, M. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01083-7 · Cited by 160
Miller, T. E., Garcia Beltran, W. F., Bard, A. Z., Gogakos, T., Anahtar, M. N., Astudillo, M. G., Yang, D., Thierauf, J., Fisch, A. S., Mahowald, G. K., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001700rr · Cited by 148
The SAFER Investigators and Field Study Team, Hellewell, J., CMMID COVID-19 working group, Russell, T., Beale, R. C. L., Kelly, G. P., Houlihan, C. F., Nastouli, E., & Kucharski, A. J. (2021) · BMC Medicine · doi:10.1186/s12916-021-01982-x · Cited by 141
Huang, Y., Pinto, M. D., Borelli, J. L., Mehrabadi, M. A., Abrihim, H., Dutt, N. D., Lambert, N., Nurmi, E. L., Chakraborty, R., Rahmani, A. M., et al. (2021) · medRxiv · doi:10.1101/2021.03.03.21252086 · Cited by 131
Defining long COVID: Going back to the start
Alwan, N. A., & Johnson, L. (2021) · Med · doi:10.1016/j.medj.2021.03.003 · Cited by 126
Self-citationMulti-organ impairment in low-risk individuals with long COVIDPreprint
Dennis, A., Wamil, M., Kapur, S., Alberts, J., Badley, A. D., Decker, G. A., Rizza, S. A., Banerjee, R., & Banerjee, A. (2020) · medRxiv · doi:10.1101/2020.10.14.20212555 · Cited by 122
The road to addressing Long Covid
Alwan, N. A. (2021) · Science · doi:10.1126/science.abg7113 · Cited by 89
Self-citationCare Dependency in Non-Hospitalized Patients with COVID-19
Vaes, A. W., Machado, F. V. C., Meys, R., Delbressine, J. M., Goërtz, Y. M. J., Herck, M. V., Houben‐Wilke, S., Franssen, F. M. E., Vijlbrief, H., Spies, Y., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092946 · Cited by 88
A negative COVID-19 test does not mean recovery
Alwan, N. A. (2020) · Nature · doi:10.1038/d41586-020-02335-z · Cited by 68
Self-citationAlwan, N. A. (2021) · Communications Medicine · doi:10.1038/s43856-021-00016-0 · Cited by 40
Self-citationLong COVID: where do we start with the case definitions?Preprint
Alwan, N. A., & Johnson, L. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/hndtm · Cited by 5
Self-citation
Cited by
Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
O'Mahoney, L. L., Routen, A., Gillies, C., Ekezie, W., Welford, A., Zhang, A., Karamchandani, U., Simms-Williams, N., Cassambai, S., Ardavani, A., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101762 · Cited by 791
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Raman, B., Bluemke, D. A., Lüscher, T. F., & Neubauer, S. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac031 · Cited by 650
Long COVID science, research and policy
Al-Aly, Z., Davis, H., McCorkell, L., Soares, L., Wulf-Hanson, S., Iwasaki, A., & Topol, E. J. (2024) · Nature Medicine · doi:10.1038/s41591-024-03173-6 · Cited by 538
Greenhalgh, T., Sivan, M., Perlowski, A., & Nikolich, J. Ž. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01136-x · Cited by 502
Metadata
- Authors
- Ziauddeen, N., Gurdasani, D., O’Hara, M. E., Hastie, C., Roderick, P., Yao, G., & Alwan, N. A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-03-08
- Volume
- 17
- Issue
- 3
- Pages
- e0264331
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W4220830275
- Cited by
- 309
- References
- 36
- FWCI
- 32.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.